Ukraine steel collapse: How EU protectionism is strangling Britain’s last ally in Europe

When protectionism becomes a weapon of war

The European Union calls Ukraine a "strategic partner." It sends weapons, funds reconstruction, and frames Kyiv’s struggle as Europe’s own. Yet when it comes to the one industry keeping Ukraine’s war economy alive—steel—Brussels is pulling up the drawbridge. New import quotas set to take effect on July 1st could "kill the Ukrainian steel industry," warns Yuriy Ryzhenkov, CEO of Metinvest, the country’s largest steelmaker. The irony? Britain, which once positioned itself as Ukraine’s most vocal supporter, is now a silent accomplice in this economic strangulation.

This isn’t just about steel. It’s about the hypocrisy of a continent that demands sacrifice from Ukraine while refusing to make any of its own.

The quotas that could break Ukraine’s back

Ukraine’s steel industry isn’t some relic of Soviet-era inefficiency. It’s a modern, export-driven sector that generated $12 billion in revenue last year—nearly 10% of the country’s GDP. Before the war, Ukraine was the world’s 13th-largest steel producer. Today, with its ports blockaded and domestic demand collapsed, exports are its lifeline. The EU is Ukraine’s largest market, absorbing 70% of its steel output in 2023.

Brussels’ new quotas will slash that by half.

The EU argues the measures are necessary to protect its own steelmakers from "unfair competition." But this framing ignores two brutal realities. First, Ukraine’s steel industry isn’t competing—it’s surviving. Second, the quotas won’t just hurt Ukraine; they’ll backfire on Europe’s own green transition. Ukrainian steel is among the cleanest in the world, produced using electric arc furnaces that emit a fraction of the CO₂ of traditional blast furnaces. By cutting off this supply, the EU is forcing itself to rely on dirtier alternatives—from China, Russia’s allies, or its own aging mills.

Britain, which imports 15% of its steel from Ukraine, has said nothing. Not a word of protest. Not even a diplomatic nudge. After Brexit, London was quick to tout its "Global Britain" credentials, positioning itself as a champion of free trade. Yet when it comes to the one trade that matters most—keeping Ukraine’s economy afloat—Britain is missing in action.

The UK’s complicity: Silence as strategy

There’s a pattern here. Britain has been conspicuously quiet on every major EU policy that undermines Ukraine’s war effort. When Brussels delayed €50 billion in aid for months, London stayed silent. When Hungary held up Sweden’s NATO accession, Britain offered no public rebuke. Now, as the EU chokes off Ukraine’s steel exports, the UK is again absent.

This isn’t neutrality. It’s cowardice.

The government’s official line is that it "supports Ukraine’s economic resilience." But resilience requires more than weapons and sanctions. It requires markets. And right now, the EU is slamming the door on the one industry that could fund Ukraine’s reconstruction without endless Western handouts.

Britain’s silence is particularly damning given its own history with steel. The UK steel industry has been in decline for decades, hollowed out by cheap imports and political neglect. Yet rather than seize this moment to advocate for a rules-based trade system that could benefit both Ukraine and British manufacturers, London is choosing to look away.

The OpenAI IPO: When tech hype meets geopolitical reality

While Brussels and London play economic chess with Ukraine’s future, Silicon Valley is making its own power move. OpenAI has filed confidentially for an IPO, with a valuation north of $850 billion. If successful, it would be one of the largest public listings in history—bigger than Saudi Aramco, bigger than Meta at its peak.

The timing is no coincidence. OpenAI’s filing comes as the US and EU ramp up AI regulation, and as China tightens its grip on semiconductor exports. The message is clear: in the new tech cold war, the West is betting everything on a handful of AI giants to outpace Beijing.

But there’s a catch. OpenAI’s valuation is built on hype, not profits. The company lost $540 million last year, and its revenue growth is slowing. Meanwhile, its flagship product—ChatGPT—is facing a crisis of trust. Deepfake scams, AI-generated misinformation, and corporate data leaks have eroded public confidence. In Britain, where AI fraud has surged by 300% in the past year, regulators are already warning that the technology is outpacing the law.

The IPO isn’t just a financial gamble. It’s a test of whether the West can still set the rules of the digital economy—or whether it’s already ceding that power to the highest bidder.

Marilyn at 100: When icons outlive their myths

A century after her birth, Marilyn Monroe is still the most photographed woman in history. A new exhibition at London’s National Portrait Gallery traces her evolution from Norma Jeane to global icon—and exposes the machinery behind the myth.

The show is a masterclass in cultural commodification. Monroe’s image wasn’t just sold; it was engineered. Every photograph, every film still, every publicity shot was designed to project a specific fantasy: the dumb blonde, the sex symbol, the tragic heroine. But the exhibition also reveals the cracks in the facade. Monroe’s own words, scribbled in notebooks and letters, paint a different picture—a woman acutely aware of her own exploitation, yet powerless to escape it.

What makes Monroe’s story relevant today isn’t just her fame. It’s the way her image was weaponized, then discarded. In an era of AI-generated influencers and deepfake porn, Monroe’s legacy is a warning: when culture becomes content, the people behind it become disposable.

The NHS’s quiet revolution: When innovation becomes a postcode lottery

In Huddersfield, a town better known for its textile mills than its tech startups, something unexpected is happening. The University of Huddersfield is building a £100 million health innovation campus, backed by private investors and NHS trusts. The goal? To turn medical breakthroughs into local jobs—and local jobs into better healthcare.

It’s a rare bright spot in Britain’s struggling health system. But it’s also a reminder of how unevenly innovation is distributed. While Huddersfield bets on biotech, hospitals in Blackpool and Bradford are cutting services. The NHS’s postcode lottery isn’t just about waiting times; it’s about who gets access to the future of medicine.

The government calls this "levelling up." But when innovation is driven by private investment rather than public need, it risks deepening the divide. Britain’s health tech boom could save lives—or it could become another symbol of a country where opportunity is a privilege, not a right.

What this tells us

Today’s stories share a common thread: power is shifting, and the old rules no longer apply.

The EU’s steel quotas reveal a continent that talks solidarity but practices protectionism. Britain’s silence exposes a government more interested in avoiding controversy than defending its allies. OpenAI’s IPO is a gamble that the future of AI will be decided by markets, not by ethics. Marilyn Monroe’s centenary reminds us that icons are made, not born—and that their legacies are often controlled by those who profit from them. And the NHS’s innovation lottery shows how unevenly the benefits of progress are distributed.

The question for Britain isn’t just what kind of country it wants to be. It’s what kind of world it’s willing to fight for.